What is the brain-eating amoeba behind the recent deaths in Kerala?

The brain-eating amoeba enters the body through the nose during swimming, travels to the brain, and destroys brain tissue causing swelling

Cancer cells
Image by kjpargeter on Freepik
Nandini Singh New Delhi
3 min read Last Updated : Jul 04 2024 | 2:05 PM IST
A 14-year-old boy undergoing treatment for primary amoebic meningoencephalitis, a rare infection caused by Naegleria fowleri, also known as the “brain-eating amoeba”, died at a private hospital in Kerala on Wednesday, according to state health officials.

The infection was traced back to a small pond where the boy had been swimming, prompting immediate preventive measures by health authorities.

This is the third reported case of this infection in Kerala since May. The rare but deadly disease has previously claimed several lives in the state. Under what circumstances can one be affected by it, and what are the associated symptoms? We explain:

What is primary amoebic meningoencephalitis?


Primary amoebic meningoencephalitis (PAM) is caused by Naegleria fowleri, a single-celled organism that lives in warm fresh water and soil. The amoeba infects people by entering the body through the nose, typically when they are swimming. Once inside, it travels to the brain, causing severe damage and inflammation.

The amoeba thrives in temperatures up to 46 degree Celsius and can be found in warm freshwater environments, such as lakes, rivers, poorly maintained swimming pools, splash pads, surf parks, and other recreational water venues.

How does ‘brain-eating amoeba’ infect people?
 

The ‘brain-eating amoeba’ infects individuals by entering through the nose during activities such as swimming. It then migrates to the brain, where it destroys brain tissue and causes swelling.

It is important to note that people cannot get infected by drinking contaminated water, and it is not communicable from person to person.

What are its symptoms?
 

Initial symptoms include headache, fever, nausea, and vomiting. As the infection progresses, symptoms can escalate to a stiff neck, confusion, seizures, hallucinations, and eventually coma.

According to the US Centers for Disease Control and Prevention (CDC), most people with primary amoebic meningoencephalitis die within 1 to 18 days after symptoms begin, usually leading to coma and death after about five days.

Treatment for primary amoebic meningoencephalitis


Currently, there are no definitive treatments for primary amoebic meningoencephalitis. Doctors use a combination of drugs, including amphotericin B, azithromycin, fluconazole, rifampin, miltefosine, and dexamethasone, but these treatments have not been consistently effective.

Past incidents of infection
 

On May 20, a five-year-old girl from Munniyoor in Malappuram died from primary amoebic meningoencephalitis after bathing in the Munniyoor river. Additionally, a 12-year-old boy from Ramanattukara, Malappuram, is in critical condition at Baby Memorial Hospital after developing symptoms such as fever, headache, and vomiting within 5-6 days of swimming in a pond.

(With PTI inputs)
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :KeraladiseaseBS Web Reportshealth

First Published: Jul 04 2024 | 2:05 PM IST

Next Story